Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Improved Endothelial Function with Combined Chelation Therapy in Thalassaemia Major.

Mark A. Tanner, MRCP, Renzo Galanello, MD, Carlo Dessi, MD, Annalisa Agus, MD, Gillian C. Smith, MSc, Mark A. Westwood, MD, Ravi Assomull, MRCP, Sunil V. Nair, MRCP, J. Malcolm Walker, MD, Dudley J. Pennell, MD

Blood (2006) 108 (11): 1770.

https://doi.org/10.1182/blood.V108.11.1770.1770

Published: 2006

Journal Articles

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

Dudley J. Pennell, Vasili Berdoukas, Markissia Karagiorga, Vasili Ladis, Antonio Piga, Athanassios Aessopos, Efstathios D. Gotsis, Mark A. Tanner, Gill C. Smith, Mark A. Westwood, Beatrix Wonke, Renzo Galanello

Blood (2006) 107 (9): 3738–3744.

https://doi.org/10.1182/blood-2005-07-2948

Published: 2006

Journal Articles

A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy with Deferoxamine and Deferiprone on Myocardial Iron in Thalassaemia Major Using Cardiovascular Magnetic Resonance.

Mark A. Tanner, MD, Renzo Galanello, MD, Carlo Dessi, MD, Mark A. Westwood, MD, Gillian C. Smith, MSc, Mohammed Khan, MSc, Sunil V. Nair, MD, J. M. Walker, MD, Dudley J. Pennell, MD

Blood (2005) 106 (11): 3655.

https://doi.org/10.1182/blood.V106.11.3655.3655

Published: 2005

Journal Articles

Multi-Centre Validation of the Cardiovascular Magnetic Resonance Multi Breath-Hold T2* Technique for Myocardial Iron Quantification in Thalassaemia Major.

Mark A. Tanner, MBBS, Taigang He, PhD, Mark A. Westwood, MD, Renzo Galanello, MD, Gildo Matta, MD, Alan R. Cohen, MD, Mark Fogel, MD, Antonio Piga, MD, Gianluca Forni, MD, Charalambos Economides, MD, David N. Firmin, PhD, Pennell J. Dudley, MD

Blood (2005) 106 (11): 3828.

https://doi.org/10.1182/blood.V106.11.3828.3828

Published: 2005

Journal Articles

Inter-Site Validation of a Single Breath Hold T2* MR Technique for Heart and Liver Iron Measurement.

Paul Kirk, MBBS, BSc, MRCP, Lisa J. Anderson, MD, Mark A. Tanner, MBBS, Renzo Galanello, MD, Gildo Matta, MD, Ru S. Tan, MD, Ivg Ng, MD, Angie Lai, MD, Kevin Chen, MD, David N. Firmin, MD, Dudley J. Pennell, MD, FRCP, FESC, FACC

Blood (2005) 106 (11): 3830.

https://doi.org/10.1182/blood.V106.11.3830.3830

Published: 2005

Journal Articles

The Effect of Combined Chelation Therapy in the Treatment of Severe Myocardial Iron Loading in Beta Thalassaemia Major.

Mark A. Tanner, MBBS, Renzo Galanello, MD, Carlo Dessi, MD, Mark A. Westwood, MD, Dudley J. Pennell, MD

Blood (2005) 106 (11): 3836.

https://doi.org/10.1182/blood.V106.11.3836.3836

Published: 2005

Journal Articles

Myocardial T2* in Patients with Cardiac Failure Secondary to Iron Overload.

Mark A. Tanner, MBBS, John B. Porter, MD, Mark A. Westwood, MD, Sunil V. Nair, MBBS, Lisa J. Anderson, MD, J. M. Walker, MD, Dudley J. Pennell, MD

Blood (2005) 106 (11): 3838.

https://doi.org/10.1182/blood.V106.11.3838.3838

Published: 2005

Journal Articles

Improved Myocardial T2* in Transfusion Dependent Anemias Receiving ICL670 (Deferasirox).

John B. Porter, MD, Mark A. Tanner, MRCP, Dudley J. Pennell, MD, Perla Eleftheriou, MD

Blood (2005) 106 (11): 3600.

https://doi.org/10.1182/blood.V106.11.3600.3600

Published: 2005

NARROW

Improved Endothelial Function with Combined Chelation Therapy in Thalassaemia Major.

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy with Deferoxamine and Deferiprone on Myocardial Iron in Thalassaemia Major Using Cardiovascular Magnetic Resonance.

Multi-Centre Validation of the Cardiovascular Magnetic Resonance Multi Breath-Hold T2* Technique for Myocardial Iron Quantification in Thalassaemia Major.

Inter-Site Validation of a Single Breath Hold T2* MR Technique for Heart and Liver Iron Measurement.

The Effect of Combined Chelation Therapy in the Treatment of Severe Myocardial Iron Loading in Beta Thalassaemia Major.

Myocardial T2* in Patients with Cardiac Failure Secondary to Iron Overload.

Improved Myocardial T2* in Transfusion Dependent Anemias Receiving ICL670 (Deferasirox).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only